See also this year's filing and all EDGAR filings for this company.
PDF Report 0001404123_2023_1Life_Healthcare_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Tenet Healthcare CORP', 'shared_tokens': {'healthcare'}}, {'other_company': 'Healthcare Services Group Inc', 'shared_tokens': {'healthcare'}}, {'other_company': 'HCA Healthcare Inc', 'shared_tokens': {'healthcare'}}, {'other_company': 'National Healthcare CORP', 'shared_tokens': {'healthcare'}}]} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4217232126183444, 'aggregate_val': 1433728000, 'exp_sum': 2479311000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 441499000, 'GeneralAndAdministrativeExpense': 415834000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 1465242000, 'DepreciationDepletionAndAmortization': 91185000, 'SellingAndMarketingExpense': 97065000, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -31514000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001404123')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001404123, 1Life Healthcare Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 1,469,578,000 |
| 1 | AssetsNonCurrent | 286,819,000 |
| 2 | AssetsCurrent | 450,939,000 |
| 3 | PropertyPlantAndEquipment | 220,314,000 |
| 4 | remainder_Assets | 5,084,000 |
| 5 | LongTermLiabilities | 618,941,000 |
| 6 | LiabilitiesCurrent | 248,574,000 |
| 7 | remainder_Liabilities | 21,233,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 441,499,000 |
| 10 | GeneralAndAdministrativeExpense | 415,834,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 1,465,242,000 |
| 13 | DepreciationDepletionAndAmortization | 91,185,000 |
| 14 | SellingAndMarketingExpense | 97,065,000 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -1,077,097,000 |
| 17 | remainder_Revenues | 1,045,547,000 |
| 18 | remainder_NetIncome | -9,666,000 |
| 19 | remainder_ComprehensiveNetIncome | -586,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,432,734,000 |
| 1 | Liabilities | 888,748,000 |
| 2 | Expenses | 1,433,728,000 |
| 3 | Revenues | 1,045,547,000 |
| 4 | StockholdersEquity | 1,543,986,000 |
| 5 | NetIncome | -397,847,000 |
| 6 | ComprehensiveNetIncome | -398,433,000 |
| 7 | BaseVar | 2,905,504,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.11 |
| 9 | EconomicCapitalRatio | 1.79 |